ワクチン製剤の課題への対処
Croda Pharmaのすべてのプラットフォームにわたるワクチン開発への解決策を、この製品カタログに記載しています。次世代ワクチンの開発において当社がどのようにお客様をサポートできるかをこの資料でご覧ください。
Whitepapers (Japanese)
Language: Japanese
Format: PDF
File size: 6.9 MB
Products
Featured
Super Refined™ Polysorbate 80
Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral.
Super Refining removes impurities (including primary...
Featured
Super Refined™ Polysorbate 20
Super Refining removes impurities, preventing adverse interactions with APIs and enhancing the stability of pharmaceutical formulations. Super Refined Polysorbates offer the complete solution when...
Featured
Alhydrogel™
One of the most widely used vaccine adjuvants, Alhydrogel is an aluminium-based adjuvant used in clinically-approved vaccines that can elicit effective Th2 immune responses.
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=DFB2292D232ABFBD17192EECC1AABCEA19C138999FEC74AA)
Featured
Adju-Phos™
Well-established as a common component in a variety of vaccines, Adju-Phos is an aluminium-based adjuvant that induces strong Th2 immune responses.
Featured
Span™ 80 pharma
Liquid W/O emulsifier and O/W emulsion stabiliser, particularly recommended for unsaturated lipid components such as oleyl alcohol or vegetable oils. Extensively used as a wetting agent and dispersant...
Featured
3D(6-acyl)-PHAD™
Immunostimulatory and highly purified, 3D(6-acyl)-PHAD activates TLR4 to induce proinflammatory cytokines and T-cells. 3D(6-acyl)-PHAD is a synthetically produced structural analogue of monophosphoryl...
Featured
PHAD™ (MPLA Analogue)
Versatile and effective, PHAD acts as a TLR4 agonist to activate proinflammatory cytokines and antigen-specific effector cells. PHAD is the first synthetic analogue of monophosphoryl lipid A (MPLA),...
